Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics
logo
Connect before LUGPA Learn more about our prostate test offerings
Call

AmeriPath, a Quest Diagnostics company, is bringing a new perspective to this year's Large Urology Group Practice Association (LUGPA) Annual Meeting. Stop by booth 106 or sign up for time with our team using the link below to discover how our digital pathology solutions provide clarity and confiderence across the care continuum.

Let's meet at LUGPA

  • Engage directly with our commercial team members at our booth
  • Discover flexible digital pathology solutions that are scalable and designed to help you improve the patient journey
  • Address GU pathology lifecycle challenges with flexible global models, technical/professional component support, and modular histopathology solutions
  • Learn about Haystack MRD® application in bladder cancer

Learn about Haystack MRD® application in bladder cancer

Haystack MRD® is an advanced tumor-informed minimal residual disease (MRD) test that detects circulating tumor DNA (ctDNA) in blood using proprietary technology that double-checks each variant to eliminate sequencing noise. This helps clinicians trust the results to more fully understand their patient’s disease status for greater confidence when making key clinical decisions.

Explore our offering
Connect with our team at LUGPA

Breadth and depth across multiple specialties

At AmeriPath, we go beyond the test as your single-source solution, delivering reliable results, efficient processes, and world-class expertise across pathology specialties by leveraging over 430 board-certified subspecialized pathologists coupled with a comprehensive menu of services. Our digital pathology solutions, enabled through AmeriPath, are flexible and scalable. Designed to empower fast collaboration, unlock crucial insights, and accelerate diagnosis and treatment, these tools can help you improve the patient journey and provide the highest-quality cancer care.

The power of AmeriPath

AmeriPath is a leading provider of genitourinary and gastroenterology (GI/GU) pathology services, with comprehensive biopsy and testing solutions. Our GI/GU offerings include

  • Immunohistochemistry and special stains
  • Comprehensive cytology testing, including FISH
  • Histopathologic evaluation by H&E stains, including use of advanced AI algorithms for prostate biopsies
  • Access to the comprehensive test menu of Quest, including Haystack MRD®.

 

 

Learn more
50-50_Photo_AdobeStock_327070396.jpg

Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.